Chemokine and Matrix Metalloproteinase Secretion by Myelin Proteolipid Protein-Specific CD8+ T Cells: Potential Roles in Inflammation

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3046-3053

  Biddison, William E ^a,e   Taub, Dennis D ^b   Cruikshank, William W ^c   Center, David M ^c   Connor, Edward W ^d   Honma, Kiri ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b SAIC FREDERICK INC   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; COLLAGENASE; CXC CHEMOKINE IP 10; CXC CHEMOKINE IP-10; CYTOKINE; EPITOPE; GELATINASE B; INTERLEUKIN 16; MACROPHAGE INFLAMMATORY PROTEIN 1; METALLOPROTEINASE; PEPTIDE; PROTEOLIPID PROTEIN;

ARTICLE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; INFLAMMATION; SECRETION;

CELL LINE; CHEMOKINES; CHEMOKINES, CXC; COLLAGENASES; CYTOKINES; EPITOPES; HUMANS; INFLAMMATION; INTERLEUKIN-16; MACROPHAGE INFLAMMATORY PROTEIN-1; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MYELIN PROTEOLIPID PROTEIN; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031110114     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Martin, R., H. McFarland, and D. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
2. Hafler, D., and H. Weiner. 1995. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144:75.
3. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299.
4. Schall, T. 1994. The chemokines. In The Cytokine Handbook. A. Thompson, ed. Academic Press, New York, p. 419.
5. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8, and RANTES. Eur. J. Immunol. 25:751.
6. Miyagishi, R., S. Kikuchi, T. Fukazawa, and K. Tashiro. 1995. Macrophage inflammatory protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129:223.
7. Cruikshank, W., D. Center, N. Nisar, B. Natke, A. Theodore, and H. Kornfeld. 1994. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic activity with CD4 expression. Proc. Natl. Acad. Sci. USA 91:5109.
8. Cruikshank, W., A. Long, R. Tarpy, H. Kornfeld, M. Carroll, L. Teran, S. Holgate, and D. Center. 1995. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am. J. Respir. Cell Mol. Bull. 13:738.
9. Luster, A., and J. Ravitch. 1987. Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducibie hypersensitive site. Mol. Cell. Biol. 7:3723.
10. Taub, D., A. Lloyd, K. Conlon, J. Wang, J. Ortaldo, A. Harada, K. Matsushima, D. Kelvin, and J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
11. Kaplan, G., A. Luster, O. Hancock, and Z. Cohn. 1987. The expression of a gamma interferon-induced protein (IP-10) in delayed-type hypersensitivity responses in skin. J. Exp. Med. 166:1098.
12. Goetzl, E., M. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. J. Immunol. 156:1.
13. Ries, C., and P. Petrides. 1995. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler 376: 345.
14. Gearing, A., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. Davidson, A. Drummond, W. Galloway, R. Gilbert, J. Gordon, T. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. Wood, and K. Wooley. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555.
15. + T-cell responses to human myelin protein-derived peptides. Prof. Natl. Acad. Sci. USA 91:10859.
16. + cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J. Neuroimmunol. In press.
17. Parker, K., M. Bednarek, and J. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163.
18. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109.
19. Storkus, W., D. Howell, R. Salter, J. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA expression. J. Immunol. 138:1657.
20. + T cells in response to MIP-1α and MIP-1β. Science 260:355.
21. Kleiner, D., and W. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218:325.
22. DiBrino, M., T. Tsuchida, R. Turner, K. Parker, J. Coligan, and W. Biddison. 1993. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 151:5930.
23. Utz, U., S. Koenig, J. Coligan, and W. Biddison. 1992. Presentation of three different viral peptides, HTLV-I Tax, HCMV gB, and influenza virus M1 is determined by common structural features of the HLA-A2.1 molecule. J. Immunol. 149:214.
24. Schall, T., K. Bacon, R. Camp, J. Kaspari, and D. Goeddel. 1993. Human macrophage inflammatory protein 1a (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1825.
25. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1β. J. Immunol. 153:4899.
26. Lloyd, A., J. Oppenheim, D. Kelvin, and D. Taub. 1996. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156:932.
27. Tanaka, Y., D. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79.
28. Roth, S., M. Carr, and T. Springer. 1995. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol. 25:3482.
29. Del Pozo, M., P. Sanchez-Mateos, M. Nieto, and F. Sanchez-Madrid. 1995. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix: involvement of cAMP signalling pathway. J. Cell Biol 131:495.
30. Karpus, W., N. Lukacs, B. McRae, R. Strieter, S. Kunkel, and S. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-1a in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003.
31. Schrum, S., P. Probst, B. Fleischer, and P. Zipfel. 1996. Synthesis of the C-C chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J. Immunol. 157:3598.
32. Loetscher, M., B. Gerber, P. Loetscher, S. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IPlO and Mig: structure, function, and expression in activated T-lympbocytes. J. Exp. Med. 184:963.
33. Swain, S., L. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. Weinberg, D. Duncan, S. Hedrick, R. Dutton, and G. Huston. 1991. Helper T cell subsets: phenotype, function, and the role of lymphokines in regulating their development. Immunol. Rev. 123:115.
34. Sharief, M., and E. Thompson. 1992. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38:27.
35. Selmaj, K., C. Raine, M. Farooq, W. Norton, and C. Brosnan. 1991. Cytokine cytotoxicity against oligodendrocytes. J. Immunol. 147:1522.
36. Sharief, M., and R. Hentges. 1992. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 326:272.
37. Hofman, F., D. Hinton, K. Johnson, and J. Merrill. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:607.
38. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF: a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
39. Sethna, M., and L. Lampson. 1991. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34:121.
40. Chin, Y., J. Cai, and K. Johnson. 1990. Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines. J. Immunol. 145:3669.
41. Bell, M., D. Taub, and V. Perry. 1996. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 74:283.
42. Gijbels, K., and L. Steinman. 1994. Gelatinase B producing cells in multiple sclerosis lesions. J. Cell. Biochem. Suppl. 18D:143.
43. Gijbels, K., S. Masure, H. Carton, and G. Opdenakker. 1992. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41:29.
44. Rosenberg, G., M. Kornfeld, E. Estrada, R. Kelley, L. Liota, and W. Stetler-Stevenson. 1992. TIMP-2 reduces proteolytic opening of the blood-brain barrier by type IV collagenase. Brain Res. 576:203.
45. Gijbels, K., S. Masure, H. Carton, A. Billiau, and G. Opdenakker. 1993. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J. Neurosci. Res. 36:432.
46. Gijbels, K., R. Galardy, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94:2177.